← SynDRA
SB-262470
SynDRA canonical compound SYN0331998 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | CASR | PTH |
| Mechanism of action | calcium receptor antagonist |
All known targets
Mechanisms of action (all sources)
- calcium receptor antagonist
- CASR ANTAGONIST
Cross-references
Synonyms
- NPS 2143
- NPS2143
- UNII-Z25PJ77W7V
- Z25PJ77W7V
- CHEMBL180672
- 2-CHLORO-6-[(2R)-3-[[1,1-DIMETHYL-2-(2-NAPHTHALENYL)ETHYL]AMINO]-2-HYDROXYPROPOXY]BENZONITRILE
- C24H25ClN2O2
- 2-chloro-6-[(2R)-2-hydroxy-3-[(2-methyl-1-naphthalen-2-ylpropan-2-yl)amino]propoxy]benzonitrile
- (R)-2-chloro-6-(2-hydroxy-3-((2-methyl-1-(naphthalen-2-yl)propan-2-yl)amino)propoxy)benzonitrile
- SB-262470A
- (+)-NPS-2143
- AC1OCFG2
- GTPL716
- SCHEMBL13597018
- EX-A017
- DTXSID10426075
- MolPort-021-805-006
- BCPP000077
- ZINC3975668
- Nps-2143
- RefChem:854783
- DTXCID50376909
- NPS-2143(SB 262470A )
- YP1
- MFCD04113010
- SB262470
- orb1706434
- orb3032952
- SCHEMBL29468181
- SCHEMBL29901569
- SCHEMBL31142208
- JLA03533
- BDBM50161093
- s2633
- AKOS025401886
- CCG-268751
- CS-0319
- NCGC00344510-01
- NCGC00344510-02
Look up SB-262470 in the interactive SynDRA portal →